Joao daCosta - 29 Dec 2023 Form 4 Insider Report for Cell MedX Corp. (STME)

Reporting relationship: Director
Issuer ticker: STME
Reported as of: 29 Dec 2023
Net transaction value: +$3,722
SEC form: 4
Accepted by SEC: 09 Jan 2024, 19:01:13 UTC
Source filing: View source filing
Reporting owner signature: Joao da Costa

Key filing fact

Joao daCosta filed Form 4 for Cell MedX Corp. (STME) on 09 Jan 2024.

Key facts

This page summarizes Joao daCosta's Form 4 filing for Cell MedX Corp. (STME).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 09 Jan 2024, 19:01.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$3,722.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CMXC transaction

Common Shares

Award

Transaction value: $3,722
Shares: +531,687
Change %: +35%
Price: $0.007000^*
Shares after: 2,061,687
Date: 29 Dec 2023
Ownership: Da Costa Management Corp.
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reporting Person acquired 531,687 shares on settlement of $3,722 owed by the Issuer to Da Costa Management Corp, a company controlled by the Reporting Person